Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2016 Filed Mar 2, 2016 22:08 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 94 | $29.67 | $2,788.98 |
DisclosureSEC source: 0001225208-16-028964 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,631 Underlying: Common Stock · 94 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 2,166 | $30.23 | $65,478.18 |
DisclosureSEC source: 0001225208-16-028805 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,878 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 1,143 | $30.23 | $34,552.89 |
DisclosureSEC source: 0001225208-16-028805 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,044 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 3,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028805 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,187 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
BOURLA ALBERTGroup President
|
GrantCommon Stock | 3,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028804 · doc4.xml · nonDerivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,961 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
DAMELIO FRANK AExecutive Vice President
|
Tax withholdingCommon Stock | 20,213 | $30.23 | $611,038.99 |
DisclosureSEC source: 0001225208-16-028806 · doc4.xml · nonDerivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,073 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
DAMELIO FRANK AExecutive Vice President
|
Tax withholdingCommon Stock | 10,087 | $30.23 | $304,930.01 |
DisclosureSEC source: 0001225208-16-028806 · doc4.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,286 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
DAMELIO FRANK AExecutive Vice President
|
GrantCommon Stock | 19,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028806 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,373 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
Dolsten MikaelPresident R&D
|
Tax withholdingCommon Stock | 9,549 | $30.23 | $288,666.27 |
DisclosureSEC source: 0001225208-16-028807 · doc4.xml · nonDerivative · entry 2 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,210 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:12 UTC |
Dolsten MikaelPresident R&D
|
GrantCommon Stock | 18,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028807 · doc4.xml · nonDerivative · entry 1 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,759 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
HILL CHARLES HExecutive Vice President
|
Tax withholdingCommon Stock | 9,462 | $30.23 | $286,036.26 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,428 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
HILL CHARLES HExecutive Vice President
|
Tax withholdingCommon Stock | 4,912 | $30.23 | $148,489.76 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,890 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
HILL CHARLES HExecutive Vice President
|
GrantCommon Stock | 9,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028808 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,802 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
JOHNSON RADY AExecutive Vice President
|
Tax withholdingCommon Stock | 1,335 | $30.23 | $40,357.05 |
DisclosureSEC source: 0001225208-16-028809 · doc4.xml · nonDerivative · entry 3 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,010 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
JOHNSON RADY AExecutive Vice President
|
Tax withholdingCommon Stock | 667 | $30.23 | $20,163.41 |
DisclosureSEC source: 0001225208-16-028809 · doc4.xml · nonDerivative · entry 2 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,345 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantCommon Stock | 1,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028809 · doc4.xml · nonDerivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,012 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
Tax withholdingCommon Stock | 3,242 | $30.23 | $98,005.66 |
DisclosureSEC source: 0001225208-16-028810 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,220 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
Tax withholdingCommon Stock | 1,618 | $30.23 | $48,912.14 |
DisclosureSEC source: 0001225208-16-028810 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,462 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028810 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,080 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
Tax withholdingCommon Stock | 6,905 | $30.23 | $208,738.15 |
DisclosureSEC source: 0001225208-16-028811 · doc4.xml · nonDerivative · entry 3 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,693 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
Tax withholdingCommon Stock | 896 | $30.23 | $27,086.08 |
DisclosureSEC source: 0001225208-16-028811 · doc4.xml · nonDerivative · entry 2 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,598 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantCommon Stock | 6,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028811 · doc4.xml · nonDerivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,494 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
OLSON LAURIE JExecutive Vice President
|
Tax withholdingCommon Stock | 2,670 | $30.23 | $80,714.10 |
DisclosureSEC source: 0001225208-16-028812 · doc4.xml · nonDerivative · entry 3 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,359 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
OLSON LAURIE JExecutive Vice President
|
Tax withholdingCommon Stock | 1,333 | $30.23 | $40,296.59 |
DisclosureSEC source: 0001225208-16-028812 · doc4.xml · nonDerivative · entry 2 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,029 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
OLSON LAURIE JExecutive Vice President
|
GrantCommon Stock | 3,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028812 · doc4.xml · nonDerivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,362 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
SUSMAN SALLYExecutive Vice President
|
Tax withholdingCommon Stock | 11,515 | $30.23 | $348,098.45 |
DisclosureSEC source: 0001225208-16-028813 · doc4.xml · nonDerivative · entry 3 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,851 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
SUSMAN SALLYExecutive Vice President
|
Tax withholdingCommon Stock | 5,747 | $30.23 | $173,731.81 |
DisclosureSEC source: 0001225208-16-028813 · doc4.xml · nonDerivative · entry 2 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,366 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantCommon Stock | 10,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028813 · doc4.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,113 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
Lewis-Hall Freda CExecutive Vice President
|
Tax withholdingCommon Stock | 10,106 | $30.23 | $305,504.38 |
DisclosureSEC source: 0001225208-16-028814 · doc4.xml · nonDerivative · entry 3 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,609 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
Lewis-Hall Freda CExecutive Vice President
|
Tax withholdingCommon Stock | 5,044 | $30.23 | $152,480.12 |
DisclosureSEC source: 0001225208-16-028814 · doc4.xml · nonDerivative · entry 2 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,715 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:13 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantCommon Stock | 9,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028814 · doc4.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,759 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:32 UTC |
READ IAN CDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 30,702 | $30.23 | $928,121.46 |
DisclosureSEC source: 0001225208-16-028816 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,375 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:32 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantCommon Stock | 60,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028816 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,664,077 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:32 UTC |
YOUNG JOHN DGroup President
|
Tax withholdingCommon Stock | 5,051 | $30.23 | $152,691.73 |
DisclosureSEC source: 0001225208-16-028817 · doc4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,292 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 28, 2016 Filed Mar 2, 2016 00:32 UTC |
YOUNG JOHN DGroup President
|
GrantCommon Stock | 11,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028817 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,343 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:03 UTC |
BOURLA ALBERTGroup President
|
GrantStock Appreciation Rights · Derivative | 138,675 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028375 · doc4.xml · derivative · entry 7 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,675 Underlying: Common Stock · 138,675 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:03 UTC |
BOURLA ALBERTGroup President
|
GrantStock Appreciation Rights · Derivative | 155,172 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028375 · doc4.xml · derivative · entry 6 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,172 Underlying: Common Stock · 155,172 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantStock Appreciation Rights · Derivative | 23,112 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028376 · doc4.xml · derivative · entry 8 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,112 Underlying: Common Stock · 23,112 shares Expires 2023-02-25 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantStock Appreciation Rights · Derivative | 25,862 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028376 · doc4.xml · derivative · entry 7 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,862 Underlying: Common Stock · 25,862 shares Expires 2021-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 4,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-028376 · doc4.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,098 F5 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
DAMELIO FRANK AExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 138,675 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028377 · doc4.xml · derivative · entry 7 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,675 Underlying: Common Stock · 138,675 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
DAMELIO FRANK AExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 155,172 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028377 · doc4.xml · derivative · entry 6 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,172 Underlying: Common Stock · 155,172 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
HILL CHARLES HExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 70,300 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · derivative · entry 7 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,300 Underlying: Common Stock · 70,300 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
HILL CHARLES HExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 78,664 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028379 · doc4.xml · derivative · entry 6 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,664 Underlying: Common Stock · 78,664 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
Dolsten MikaelPresident R&D
|
GrantStock Appreciation Rights · Derivative | 138,675 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028378 · doc4.xml · derivative · entry 7 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,675 Underlying: Common Stock · 138,675 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
Dolsten MikaelPresident R&D
|
GrantStock Appreciation Rights · Derivative | 155,172 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028378 · doc4.xml · derivative · entry 6 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,172 Underlying: Common Stock · 155,172 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 31,972 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028380 · doc4.xml · derivative · entry 7 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,972 Underlying: Common Stock · 31,972 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 35,776 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028380 · doc4.xml · derivative · entry 6 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,776 Underlying: Common Stock · 35,776 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 84,746 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028381 · doc4.xml · derivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,746 Underlying: Common Stock · 84,746 shares Expires 2023-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2016 Filed Feb 26, 2016 20:05 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 94,828 | $0.00 Strike: $30.59 | $0.00 |
DisclosureSEC source: 0001225208-16-028381 · doc4.xml · derivative · entry 6 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,828 Underlying: Common Stock · 94,828 shares Expires 2021-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.